RE104 Radiolabeled Mass Balance (hAME) Study
NCT07146191
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participant Study
Interventions
DRUG:
2-[14C]-RE104 for Injection
Sponsor
Reunion Neuroscience Inc